nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect
|
Zhou, Jianqing |
|
2012 |
130 |
4 |
p. 602-606 5 p. |
artikel |
2 |
Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells
|
Zhou, Hong |
|
2012 |
130 |
4 |
p. e229-e235 nvt p. |
artikel |
3 |
Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells
|
Motoki, Yukari |
|
2012 |
130 |
4 |
p. 667-673 7 p. |
artikel |
4 |
Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time
|
Gudmundsdottir, Brynja R. |
|
2012 |
130 |
4 |
p. 674-681 8 p. |
artikel |
5 |
Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis
|
Westerlund, Eli |
|
2012 |
130 |
4 |
p. 649-653 5 p. |
artikel |
6 |
Diversity of Human Plasma Protein C Inhibitor
|
Saito, Akio |
|
2012 |
130 |
4 |
p. 661-666 6 p. |
artikel |
7 |
Editorial Board
|
|
|
2012 |
130 |
4 |
p. IFC- 1 p. |
artikel |
8 |
Eosinophil count predicts mortality following percutaneous coronary intervention
|
Toor, Iqbal S. |
|
2012 |
130 |
4 |
p. 607-611 5 p. |
artikel |
9 |
Eosinophils and risk stratification of patients treated by coronary stenting
|
Cosentino, Nicola |
|
2012 |
130 |
4 |
p. 571-573 3 p. |
artikel |
10 |
Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y12 antagonists in an ex-vivo canine model
|
Ravnefjord, Anna |
|
2012 |
130 |
4 |
p. 622-628 7 p. |
artikel |
11 |
Fibrin clot properties in women heterozygous for factor V Leiden mutation: Effects of oral contraceptives
|
Krzek, Marzena |
|
2012 |
130 |
4 |
p. e216-e221 nvt p. |
artikel |
12 |
Heparin and platelet activation
|
Jagroop, I Anita |
|
2012 |
130 |
4 |
p. 685- 1 p. |
artikel |
13 |
I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle
|
Lu, Na |
|
2012 |
130 |
4 |
p. e209-e215 nvt p. |
artikel |
14 |
Improved point-of-care identification of hyperfibrinolysis is needed
|
Larsen, Ole H. |
|
2012 |
130 |
4 |
p. 690-691 2 p. |
artikel |
15 |
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting
|
Ciuti, Gabriele |
|
2012 |
130 |
4 |
p. 591-595 5 p. |
artikel |
16 |
Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis
|
Sasaki, Tomoyuki |
|
2012 |
130 |
4 |
p. e222-e228 nvt p. |
artikel |
17 |
Is there any need for a TAFI(a) inhibitor as thrombolytic drug?
|
Vercauteren, Ellen |
|
2012 |
130 |
4 |
p. 574-575 2 p. |
artikel |
18 |
Lack of association between TLR4 Asp299Gly polymorphism and atherosclerosis: evidence from meta-analysis
|
Zhang, Kui |
|
2012 |
130 |
4 |
p. e203-e208 nvt p. |
artikel |
19 |
Lack of evidence for association between factor XIII-A Val34Leu polymorphism and ischemic stroke: A meta-analysis of 8,800 subjects
|
Li, Binghu |
|
2012 |
130 |
4 |
p. 654-660 7 p. |
artikel |
20 |
Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model
|
Hampton, Anna L. |
|
2012 |
130 |
4 |
p. 640-645 6 p. |
artikel |
21 |
Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: A pediatric experience
|
Moruf, A. |
|
2012 |
130 |
4 |
p. 612-615 4 p. |
artikel |
22 |
Platelet aggregometry in the presence of PGE1 provides a reliable method for cilostazol monitoring
|
Satoh, Kaneo |
|
2012 |
130 |
4 |
p. 616-621 6 p. |
artikel |
23 |
Regulatory, policy and quality update for venous thromboembolism and stroke in United States hospitals
|
Mahan, Charles E. |
|
2012 |
130 |
4 |
p. 586-590 5 p. |
artikel |
24 |
Response to: Heparin and platelet activation, Jagroop-Dearing & Mikhailidis
|
Yagi, Mayumi |
|
2012 |
130 |
4 |
p. 686- 1 p. |
artikel |
25 |
Risk factors for venous thromboembolism in pre-and postmenopausal women
|
Bergendal, Annica |
|
2012 |
130 |
4 |
p. 596-601 6 p. |
artikel |
26 |
Seasonal variation in the occurrence of venous thromboembolism: A report from the Korean Venous Thromboembolism Working Party
|
Jang, Moon Ju |
|
2012 |
130 |
4 |
p. e199-e202 nvt p. |
artikel |
27 |
Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study
|
Vik, Anders |
|
2012 |
130 |
4 |
p. e236-e237 nvt p. |
artikel |
28 |
The APC-PCI concentration as an early marker of activation of blood coagulation
|
Bremme, K. |
|
2012 |
130 |
4 |
p. 636-639 4 p. |
artikel |
29 |
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo
|
Van De Craen, Britt |
|
2012 |
130 |
4 |
p. 576-585 10 p. |
artikel |
30 |
The impact of Cardiopulmonary bypass on Factor XIII levels in children
|
Attard, C. |
|
2012 |
130 |
4 |
p. e238-e239 nvt p. |
artikel |
31 |
The intron 7 -33T>C polymorphism in TFPI gene and cerebral venous thrombosis: Evidence for a protective role
|
Prabhakar, Puttachandra |
|
2012 |
130 |
4 |
p. 687-689 3 p. |
artikel |
32 |
Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model
|
Laing, Susan T. |
|
2012 |
130 |
4 |
p. 629-635 7 p. |
artikel |
33 |
Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis
|
Vicente, Cristina P. |
|
2012 |
130 |
4 |
p. 646-648 3 p. |
artikel |
34 |
Unsuspected visceral venous thrombosis, in patients with cancer of the gastrointestinal system
|
Bozas, George |
|
2012 |
130 |
4 |
p. 682-684 3 p. |
artikel |